Cutler Group LP Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Cutler Group LP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$144.95 - $152.29 $826,214 - $868,053	-5,700 Reduced 90.48%	600 $1,000
Q2 2022 Aug 04, 2022	SELL	$83.14 - $145.99 $1.08 Million - $1.9 Million	-13,000 Reduced 67.36%	6,300 $49,000
Q1 2022 Apr 14, 2022	BUY	$110.08 - $142.92 $506,368 - $657,432	4,600 Added 31.29%	19,300 $70,000
Q4 2021 Jan 18, 2022	BUY	$99.73 - $148.48 $1.45 Million - $2.15 Million	14,500 Added 7250.0%	14,700 $260,000
Q2 2021 Jul 19, 2021	SELL	$65.78 - $105.02 $335,478 - $535,602	-5,100 Reduced 96.23%	200 $5,000
Q1 2021 Apr 26, 2021	SELL	$64.07 - $91.75 $890,572 - $1.28 Million	-13,900 Reduced 72.4%	5,300 $2,000
Q4 2020 Jan 21, 2021	SELL	$65.07 - $98.24 $227,744 - $343,840	-3,500 Reduced 15.42%	19,200 $204,000
Q3 2020 Oct 27, 2020	SELL	$59.04 - $77.95 $413,280 - $545,650	-7,000 Reduced 23.57%	22,700 $65,000
Q2 2020 Jul 22, 2020	BUY	$29.01 - $74.23 $684,636 - $1.75 Million	23,600 Added 386.89%	29,700 $370,000
Q4 2019 Feb 06, 2020	SELL	$40.86 - $57.65 $147,096 - $207,540	-3,600 Reduced 37.11%	6,100 $40,000
Q3 2019 Oct 28, 2019	BUY	$37.38 - $49.47 $235,494 - $311,661	6,300 Added 185.29%	9,700 $25,000
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $131,307 - $221,133	3,300 Added 3300.0%	3,400 $10,000
Q1 2019 May 10, 2019	SELL	$34.52 - $53.29 $283,064 - $436,978	-8,200 Reduced 98.8%	100 $0
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $186,667 - $286,848	8,300 New	8,300 $8,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.